These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 2499268

  • 21. [Selective enhancement of tumor blood flow and drug delivery to brain tumors in experimental rat gliomas under angiotensin II-induced hypertension].
    Ogasawara H, Kiya K, Kurisu K, Hotta T, Mikami T, Sugiyama K, Uozumi T.
    No To Shinkei; 1991 Jul; 43(7):657-62. PubMed ID: 1910950
    [Abstract] [Full Text] [Related]

  • 22. Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy.
    Adam JF, Joubert A, Biston MC, Charvet AM, Peoc'h M, Le Bas JF, Balosso J, Estève F, Elleaume H.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):603-11. PubMed ID: 16338098
    [Abstract] [Full Text] [Related]

  • 23. [Chemotherapeutic strategy in rat brain tumor cells resistant to ACNU using an in vitro colony formation assay].
    Mineura K, Sasaki J, Fushimi S, Sasajima H, Ishino Y, Kowada M.
    No To Shinkei; 1989 Sep 01; 41(9):927-32. PubMed ID: 2590562
    [Abstract] [Full Text] [Related]

  • 24. [Pharmacokinetics and antitumor activity of MX2, a new morpholino anthracycline in brain tumor intracerebral transplanted in rats].
    Kiya K, Ogasawara H, Fujita H, Sugiyama K, Kurisu K, Kawamoto K, Uozumi T, Shinkai H.
    Gan To Kagaku Ryoho; 1993 Apr 01; 20(5):631-5. PubMed ID: 8470921
    [Abstract] [Full Text] [Related]

  • 25. [Possibility of overcoming ACNU resistance in ACNU-resistant sublines of rat brain tumors in vitro by a calmodulin inhibitor].
    Yoshida T, Shimizu K, Mogami H, Sakamoto Y, Egawa T.
    No Shinkei Geka; 1987 Feb 01; 15(2):143-9. PubMed ID: 3470626
    [Abstract] [Full Text] [Related]

  • 26. Long-term survival in a rodent brain tumor model by bradykinin-enhanced intra-arterial delivery of a therapeutic herpes simplex virus vector.
    Rainov NG, Dobberstein KU, Heidecke V, Dorant U, Chase M, Kramm CM, Chiocca EA, Breakefield XO.
    Cancer Gene Ther; 1998 Feb 01; 5(3):158-62. PubMed ID: 9622099
    [Abstract] [Full Text] [Related]

  • 27. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM, Okada H, Brissette-Storkus CS, Villa LA, Attanucci J, Lotze MT, Pollack IF, Bozik ME, Chambers WH.
    Cancer Res; 2000 May 01; 60(9):2449-57. PubMed ID: 10811123
    [Abstract] [Full Text] [Related]

  • 28. Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study.
    Côté J, Savard M, Bovenzi V, Dubuc C, Tremblay L, Tsanaclis AM, Fortin D, Lepage M, Gobeil F.
    Neuropeptides; 2010 Apr 01; 44(2):177-85. PubMed ID: 20080302
    [Abstract] [Full Text] [Related]

  • 29. Synchrotron microbeam radiation therapy for rat brain tumor palliation-influence of the microbeam width at constant valley dose.
    Serduc R, Bouchet A, Bräuer-Krisch E, Laissue JA, Spiga J, Sarun S, Bravin A, Fonta C, Renaud L, Boutonnat J, Siegbahn EA, Estève F, Le Duc G.
    Phys Med Biol; 2009 Nov 07; 54(21):6711-24. PubMed ID: 19841517
    [Abstract] [Full Text] [Related]

  • 30. [Chemotherapy for experimental subarachnoid dissemination model of brain tumor].
    Yamashita T, Shinonaga M, Ishiwata Y, Nishimura S, Murai M, Kyuma Y, Kuwabara T.
    No Shinkei Geka; 1984 Jan 07; 12(1):47-53. PubMed ID: 6585681
    [Abstract] [Full Text] [Related]

  • 31. Influence of modes of ACNU administration on tissue and blood drug concentration in malignant brain tumors.
    Hori T, Muraoka K, Saito Y, Sasahara K, Inagaki H, Inoue Y, Adachi S, Anno Y.
    J Neurosurg; 1987 Mar 07; 66(3):372-8. PubMed ID: 3469331
    [Abstract] [Full Text] [Related]

  • 32. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
    Weller M, Müller B, Koch R, Bamberg M, Krauseneck P, Neuro-Oncology Working Group of the German Cancer Society.
    J Clin Oncol; 2003 Sep 01; 21(17):3276-84. PubMed ID: 12947063
    [Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
    Shapiro WR, Voorhies RM, Hiesiger EM, Sher PB, Basler GA, Lipschutz LE.
    Cancer Res; 1988 Feb 01; 48(3):694-701. PubMed ID: 3335031
    [Abstract] [Full Text] [Related]

  • 34. [Overcoming of ACNU resistance in an ACNU-resistant subline of rat C6 glioma in vivo through enhanced effect of ACNU by calmodulin inhibitor].
    Yoshida T, Shimizu K, Hayakawa T, Mogami H, Sakamoto Y, Egawa T.
    No Shinkei Geka; 1987 Mar 01; 15(3):261-7. PubMed ID: 3474542
    [Abstract] [Full Text] [Related]

  • 35. [Application of interleukin 1 in the treatment of malignant gliomas with special reference to the experimental combination therapy with ACNU].
    Tanaka S.
    Gan To Kagaku Ryoho; 1990 Jun 01; 17(6):1157-64. PubMed ID: 2350191
    [Abstract] [Full Text] [Related]

  • 36. [Treatment of malignant gliomas by selective intraarterial infusion chemotherapy with high-dose ACNU and autologous bone marrow transplantation--preliminary report].
    Nakagawa H, Murasawa A, Taki T, Nakajima S, Niiyama K, Furuta Y, Fujita T, Tsuruzono K, Nakamura H, Shibata H.
    Gan To Kagaku Ryoho; 1991 Nov 01; 18(14):2435-40. PubMed ID: 1659327
    [Abstract] [Full Text] [Related]

  • 37. [Circumvention of ACNU-resistance in rat glioma cells by pretreatment with O6-methylguanine].
    Mineura K, Fushimi S, Sasaki J, Sasajima H, Ishino Y, Kowada M.
    Gan To Kagaku Ryoho; 1989 Feb 01; 16(2):259-62. PubMed ID: 2919893
    [Abstract] [Full Text] [Related]

  • 38. Radiofrequency electromagnetic fields have no effect on the in vivo proliferation of the 9L brain tumor.
    Higashikubo R, Culbreth VO, Spitz DR, LaRegina MC, Pickard WF, Straube WL, Moros EG, Roti JL.
    Radiat Res; 1999 Dec 01; 152(6):665-71. PubMed ID: 10581537
    [Abstract] [Full Text] [Related]

  • 39. Increase in brain tumor permeability in glioma-bearing rats with nitric oxide donors.
    Yin D, Wang X, Konda BM, Ong JM, Hu J, Sacapano MR, Ko MK, Espinoza AJ, Irvin DK, Shu Y, Black KL.
    Clin Cancer Res; 2008 Jun 15; 14(12):4002-9. PubMed ID: 18559623
    [Abstract] [Full Text] [Related]

  • 40. Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting.
    Brigger I, Morizet J, Aubert G, Chacun H, Terrier-Lacombe MJ, Couvreur P, Vassal G.
    J Pharmacol Exp Ther; 2002 Dec 15; 303(3):928-36. PubMed ID: 12438511
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.